| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 22, 2024 | NTRA Natera, Inc. | Moshkevich Solomon | President, Clinicaldiagnostics | Sell | 550 | $120.44 | $66,241.10 | -0.2% | +39.6% | +56.7% | |
| Oct 22, 2024 | NTRA Natera, Inc. | Brophy Michael Burkes47 | Chief Financial Officer | Sell | 1,062 | $120.46 | $127,932.28 | -0.7% | +39.6% | +56.7% | |
| Oct 22, 2024 | NTRA Natera, Inc. | Chapman Steven Leonard56 | CEO And President | Sell | 2,602 | $120.52 | $313,597.08 | -0.7% | +39.6% | +56.7% | |
| Oct 22, 2024 | NTRA Natera, Inc. | Rabinowitz Daniel48 | Sec. And Chief Legal Officer | Sell | 816 | $120.46 | $98,298.04 | -0.2% | +39.6% | +56.7% | |
| Oct 15, 2024 | GRAL Grail, Inc. | Ragusa Robert P | Chief Executive Officer | Sell | 123,454 | $14.02 | $1,730,825.08 | -16.8% | +32.5% | +439.0% | |
| Oct 15, 2024 | NTRA Natera, Inc. | Chapman Steven Leonard56 | CEO And President | Sell | 4,523 | $130.40 | $589,796.94 | -2.3% | +31.2% | +39.1% | |
| Oct 14, 2024 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 5,127 | $32.27 | $165,463.67 | -1.9% | -23.7% | -34.7% | |
| Oct 11, 2024 | MYGN Myriad Genetics Inc | Diaz Paul J74 | President And CEO | Sell | 15,000 | $22.93 | $343,950.00 | -1.5% | -38.4% | -68.9% | |
| Oct 9, 2024 | RVTY Revvity, Inc. | Vohra Tajinder S75 | Please See Remarks | Sell | 2,154 | $121.73 | $262,201.68 | -5.2% | -4.0% | -24.6% | |
| Oct 9, 2024 | TWST Twist Bioscience Corp | Laponis Adam58 | Chief Financial Officer | Sell | 856 | $41.81 | $35,791.07 | -1.2% | +10.1% | -23.1% | |
| Oct 9, 2024 | GRAL Grail, Inc. | Ding Chun R84 | - | Buy | 78,829 | $13.00 | $1,024,698.08 | +0.6% | +38.2% | +450.1% | |
| Oct 8, 2024 | EXAS Exact Sciences Corp | Baranick Brian75 | EVP, Gm, Precision Oncology | Sell | 929 | $70.00 | $65,030.00 | -6.8% | -15.7% | -13.5% | |
| Oct 8, 2024 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 2,562 | $30.27 | $77,549.18 | -1.0% | -2.2% | -21.4% | |
| Oct 8, 2024 | RVTY Revvity, Inc. | Vohra Tajinder S75 | Please See Remarks | Sell | 4,307 | $122.34 | $526,909.86 | -4.5% | -5.3% | -24.8% | |
| Oct 7, 2024 | CSTL Castle Biosciences Inc | Bradbury Daniel69 | Director | Sell | 7,867 | $29.44 | $231,628.08 | -20.0% | -0.5% | -22.4% | |
| Oct 4, 2024 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 2,565 | $28.73 | $73,702.71 | -0.9% | -4.5% | -22.6% | |
| Oct 2, 2024 | IMDX Insight Molecular Diagnostics Inc. | Broadwood Partners, L.P.60 | 10% Owner | Buy | 1,315,339 | $2.95 | $3,877,619.37 | +11.8% | -22.0% | +9.5% | |
| Oct 2, 2024 | IMDX Insight Molecular Diagnostics Inc. | James Andrea S.68 | Chief Financial Officer | Buy | 33,670 | $2.97 | $99,999.90 | New | -22.0% | +9.5% | |
| Oct 2, 2024 | TWST Twist Bioscience Corp | Leproust Emily M.77 | Chief Executive Officer | Sell | 13,605 | $43.21 | $587,885.66 | -2.7% | +7.4% | -29.1% | |
| Oct 2, 2024 | TWST Twist Bioscience Corp | Cho Dennis70 | See Remarks | Sell | 3,104 | $43.21 | $134,126.94 | -4.0% | +7.4% | -29.1% | |
| Oct 2, 2024 | TWST Twist Bioscience Corp | Finn Patrick John73 | President And COO | Sell | 6,865 | $43.21 | $296,643.52 | -4.1% | +7.4% | -29.1% | |
| Oct 2, 2024 | TWST Twist Bioscience Corp | Green Paula69 | SVP Of Human Resources | Sell | 3,310 | $43.21 | $143,028.41 | -3.8% | +7.4% | -29.1% | |
| Oct 1, 2024 | NTRA Natera, Inc. | Sheena Jonathan46 | Director, Co-founder | Sell | 5,700 | $125.64 | $716,136.97 | -0.5% | +24.7% | +27.1% | |
| Sep 27, 2024 | A Agilent Technologies, Inc. | McDonnell Padraig71 | President And CEO | Sell | 47 | $150.00 | $7,050.00 | -0.2% | -8.3% | -16.7% | |
| Sep 26, 2024 | A Agilent Technologies, Inc. | Grau Dominique70 | Senior Vice President | Sell | 15,000 | $145.00 | $2,175,000.00 | -14.7% | -7.4% | -15.9% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.